• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDNAG
DNAPrint Genomics Inc
640.0
0.0x
---
United StatesRMTG
Regenerative Medical Technology Group Inc
395.0K
0.0x
---
United StatesINFIQ
Infinity Pharmaceuticals Inc
90.0
0.0x
---
United StatesADYX
Adynxx Inc
580.0
0.0x
---
United StatesSEELQ
Seelos Therapeutics Inc
170.0K
0.0x
---
United StatesDZCA
Drazcanna Inc
164.2K
0.0x
---
As of 2024-11-22

Company Information

DNAPrint genomics, Inc. is a development-stage pharmaceutical company. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The Company generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The Company provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.

Contact Information

Headquarters
505 Paradise Rd Ste#281SWAMPSCOTT, MA, United States 01907
Phone
941-366-3400
Fax
---

Executives

Chairman of the Board, Chief Medical Officer
Hector Gomez
Chief Accounting Officer
Karen Surplus
Chief Scientific Officer, Secretary, Director
Tony Frudakis

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$640.00
Revenue (TTM)
$1.9M
Shares Outstanding
644.6M
DNAPrint Genomics Inc does not pay a dividend.
Beta
---
EPS
$-0.01
Book Value
$-0.01
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-326.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.